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Polychlorinated dibenzo-p-dioxins and dibenzo-
furans (henceforth jointly referred to as dioxins)
belong to the group of most toxic substances
known and have been associated with malig-
nancy, congenital malformations, immuno-
suppression, and hematologic disturbances
(Neubert et al. 1993; Pluim et al. 1994; ten
Tusscher 2002; ten Tusscher et al. 1999, 2000;
Vos et al. 1998; Ziegler 1997). Dioxins are
formed as waste products of combustion
processes, and municipal incinerators are
among the primary sources of these com-
pounds in the Netherlands. Heating of poly-
chlorinated biphenyls (PCBs) is a notable
source of polychlorinated dibenzofurans.
Dioxins, which are poorly degradable in nature,
persist in the environment and accumulate in
the food chain via fish oils and animal fats
(Theelen et al. 1993). These polychlorinated
aromatic compounds are highly lipophilic and
in mammals are stored primarily in adipose tis-
sues. Their lipophilicity allows them to readily
pass the placenta, whereupon they are stored in
fetal adipose tissues (Krowke et al. 1990; van
Wijnen et al. 1990).
In 1979, leakage of PCBs and polychlori-
nated dibenzofurans into rice oil caused a
large-scale human poisoning in Taiwan, called
Yu-Cheng disease. The children born to the
poisoned mothers, and thus exposed in the
womb to a high dose of PCBs and furans,
developed severe respiratory problems during
the first 6 months of life, and 25% of these
babies died before 4 years of age because of
lung diseases. Those who survived had res-
piratory sequelae, such as pneumonia, which
endured until 10 years of age, after which time
a clinical improvement was seen. Additionally,
the incidence of otitis media was increased and
became a chronic problem in these children,
many of whom developed cholesteatomas
before 10 years of age (Guo 1999).
In 1986, high dioxin concentrations in the
breast milk of Dutch mothers was reported,
followed by similar ﬁndings in other industri-
alized countries (van den Berg et al. 1986;
WHO 1989, 1996). This information indi-
cated that fetuses and breast-fed children are
exposed to relatively high “background”
dioxin levels.
Pluim et al. (1994), studying the same
group of children as the present cohort,
found thrombocyte counts to be signiﬁcantly
decreased during the perinatal period, in rela-
tion to increasing postnatal dioxin exposure.
The thrombocyte count was not performed at
the 30-month follow-up (Ilsen et al. 1996).
Pluim et al. (1994) also found a reduced num-
ber of granulocytes in relation to prenatal
dioxin exposure. This was no longer evident at
the 30-month follow-up performed by Ilsen et
al. (1996). Similarly, Weisglas-Kuperus et al.
(1995, 2000) found reduced numbers of gran-
ulocytes during the perinatal period and an
increase in infectious diseases, such as otitis
media and chicken pox. At follow-up after
approximately 2 years, both the aforemen-
tioned Dutch studies (Ilsen et al. 1996;
Weisglas-Kuperus et al. 2000) revealed that
the previous lowering of these white blood
cells was no longer evident. In Japanese breast-
fed infants, the CD4+ and CD8+ counts and
the ratio between the two lymphocyte subsets
were shown to be influenced by dioxins
(Nagayama et al. 1998).
Presently, very little is known about the
effects of perinatal dioxin exposure on the
long-term health of children. Perinatal expo-
sure to dioxins and related compounds may
have consequences spanning many years, pos-
sibly because of their long half-life and their
influence on homeostatic set points during
the various developmental windows (Hurst et
al. 2000; Weisglas-Kuperus et al. 2000).
Consequently, we hypothesized that perinatal
exposure to background levels of dioxins in the
Netherlands would cause a persistent decrease
in circulating thrombocyte counts. Similarly,
the white blood cell counts could also be
expected to be inﬂuenced in this manner.
In our ongoing study of the development
of children with documented perinatal dioxin
exposure, we determined various hematologic
and immunologic parameters and possible
clinical effects of the perinatal exposure, such
as infections and allergy.
The medical ethics committees of De
Heel Zaans Medical Centre (Zaandam, The
Netherlands) and of the Academic Medical
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Perinatal exposure to Dutch “background” dioxin levels in 1990 was high, but comparable with that
of other industrialized Western European countries. Exposure during the sensitive perinatal period
may cause permanent disturbances. Therefore, we assessed the health status and various hematologic
and immunologic parameters among our longitudinal cohort. A medical history was taken and
venipuncture performed in a longitudinal cohort of 27 healthy 8-year-old children who had docu-
mented perinatal dioxin exposure. Linear regression revealed a decrease in allergy in relation to prena-
tal (p = 0.02) and postnatal (p = 0.03) dioxin exposure. Increases in CD4+ T-helper cells (p = 0.006)
and in CD45RA+ cells (p = 0.02) were seen in relation to postnatal exposure. A persistently decreased
platelet count (p = 0.04) and increased thrombopoietin concentration (p = 0.03) were seen in relation
to postnatal exposure. This follow-up has shown a decrease in allergy, persistently decreased thrombo-
cytes, increased thrombopoietin, and increased CD4+ T-helper and increased CD45RA+ cell counts.
This study provides indications of effects at the stem cell level of perinatal dioxin exposure, persisting
until minimally 8 years after birth. Key words: allergy, dioxin, hematology, human, immunology,
pediatrics, perinatal, T cells. Environ Health Perspect 111:1519–1523 (2003). doi:10.1289/ehp.5715
available via http://dx.doi.org/ [Online 14 May 2003]
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Informed consent was obtained from the chil-
dren and their parents/guardians.
Materials and Methods
Subjects. Eight years after Pluim et al.’s (1994)
study, the study participants were again con-
tacted. The perinatal dioxin exposure is docu-
mented for all these study participants. The
children were born to healthy, well-nourished
Caucasian women, between 23 and 38 years
old (mean = 29.2 years), who intended to
breast-feed for a minimum of 2 months. Their
obstetrician or midwife recruited the mothers.
Of the original 35 mother–infant pairs, one
child was untraceable, four withdrew from the
study, and three declined venipuncture, leav-
ing 27 children in this follow-up study. The
nonparticipants introduced no population
bias, because their prenatal and postnatal
exposures were spread across the group range
(dioxin toxic equivalents: 9.05, 13.75, 19.95,
21.62, 30.52, 38.25, 47.16, 62.65). Table 1
summarizes the characteristics of the cohort.
The children underwent blood withdrawal
on one of two Saturday afternoons in the
spring of 1998 at De Heel Zaans Medical
Centre. The dioxin toxic equivalency and
cumulative toxic equivalency values as deter-
mined by Pluim et al. (1994) in the breast milk
of their mothers were used as such within this
follow-up study. Briefly, the concentration
of dioxins, using the International Toxic
Equivalency Factor (I-TEQ) method, in the
mother’s breast milk shortly after having given
birth was taken as the prenatal dioxin exposure
level of the child. The postnatal cumulative
dioxin exposure was calculated as breast milk
dioxin concentration multiplied by the amount
of breast milk ingested during the breast-feed-
ing period of the child. We assumed a 2.5% fat
concentration in the milk, 700 g of daily milk
intake during the exclusively breast-feeding
period, and 350 g daily intake during the tran-
sition period to formula feeding (Pluim et al.
1994). Dioxin-like PCBs are not included in
this calculation. To approximate the total
dioxin concentration (i.e., dioxins plus dioxin-
like PCBs), the dioxin concentrations, as pre-
sented in this study, need to be doubled,
according to measurements done by Liem and
Theelen (1997). Formula feeding, which
replaces animal fats with plant fats, has unde-
tectable levels of dioxins (Weisglas-Kuperus et
al. 2000).
The mothers kept a diary during the
breast-feeding period for data validation. The
average length of breast-feeding was nearly
3 months (88 days), with the longest period
being 6 months and a range of 1 week to
6 months. For the 27 participants, the prena-
tal dioxin exposure ranged from 8.74 to 46.6
(mean = 27.8) ng TEQ/kg fat (dioxin TEQ
per kilogram fat, measured in breast milk).
The postnatal exposure ranged from 4.34 to
123.72 ng (mean = 43.4 ng) TEQ dioxin.
These are exclusively dioxins and furans. The
exposure is equivalent to the background
exposures in The Netherlands in general dur-
ing that period (Koopman-Esseboom et al.
1994; van den Berg et al. 1986; WHO 1989,
1996). Later (childhood) dioxin exposures are
about 25 times less than during the fetal and
breast-feeding period, and it can safely be
assumed that all the subjects had similar child-
hood exposures because they all had similar
diets (Patandin et al. 1999).
Urinary mercury and blood lead levels were
determined. The mercury levels were all
<1µg/L, with the exception of one child who
had a level of 5 µg/L, and the lead levels ranged
from 16 to 24 µg/L. All mercury and lead
values were low and within the Dutch accept-
able levels. No relation was seen between lead
and mercury levels and the outcomes tested, so
it seems unlikely that lead and mercury toxicity
would confound the results.
Medical history. A complete medical his-
tory was taken for each child, and a brief his-
tory was taken of the families of the children.
Among other complaints, such as coughing
spells and dyspnea, histories of asthma, bron-
chitis, pneumonia, otitis, chicken pox, measles,
and allergies were noted. Allergies to milk and
chicken products were the only food allergies
we noted. Hay fever and allergy to animals and
to dust mites were noted as allergy. A physi-
cian, mainly the family general practitioner,
reportedly diagnosed all the allergies.
Hematology and immunology. The follow-
ing parameters were determined in venous
blood, collected in EDTA-coated tubes, using
routine procedures: hemoglobin (Hb), hemat-
ocrit, erythrocytes (red blood cells, RBCs),
RBC mean volume (MCV), mean Hb mass
of RBCs, mean Hb concentration of RBCs,
leukocytes and differential blood counts, and
platelets. Additionally, centrifuged plasma was
saved and frozen. This was later used for meas-
uring the thrombopoietin concentrations,
which was performed using a monoclonal
antibody–based sandwich enzyme-linked
immunosorbent assay, as described previously
(Folman et al. 1997). Thrombopoietin, a reg-
ulatory protein that is continually synthesized
at a constant level by the liver, is necessary for
regulating platelet numbers in the blood.
Megakaryocytes bind the protein to produce
thrombocytes in the bone marrow, and circu-
lating platelets bind and remove thrombo-
poietin from the circulation, resulting in a
feedback mechanism (Nathan and Orkin
1998).
Phenotyping white blood cells by flow
cytometry. The following monoclonal anti-
bodies were used: monoclonal antibodies
including the Simultest IMK-lymphocyte kit
(No. 340182; Becton Dickinson and Co.,
Alphen a/d Rijn, The Netherlands) [CD45-
FITC/CD14-PE, isotype control, CD3-
FITC/CD19-PE, CD3-FITC/CD4-PE,
CD3-FITC/CD8-PE, CD3-FITC/CD16-PE
and/or CD3-FITC/CD56-PE (PE, phycoery-
thrine; FITC, ﬂuorescein isothiocyanate)]. In
addition, CD45RO-PE, CD45RA-PE, and
CD29-PE were used in combination with
CD4-FITC. All materials were obtained from
Becton Dickinson (San Jose, CA, USA). The
staining method was performed in accordance
with the manufacturer’s factory manual
(Becton Dickinson), with some modiﬁcations.
In brief, all incubations were carried out in V-
bottom microtiter plates at 4°C. Microtiter
wells were ﬁlled with 45 µL of EDTA-treated
blood and 10 µL of monoclonal antibodies
(combined) and incubated for 30 min at room
temperature. Red cells were lysed with 160 µL
lysing ﬂuid for 10 min and centrifuged at 300
× g for 5 min. Cells were washed twice in 150
µL 0.1% NaN3 in phosphate-buffered saline
and centrifuged at 300 × g for 5 min. Finally,
the stained cell suspension was ﬁxed in 100 µL
1% paraformaldehyde. Cells were stored in
the dark, at 4°C. Immunoﬂuorescence analysis
was performed using a single-laser FACScan
(Becton Dickinson Immunocytometry,
Mountain View, CA, USA).
Statistics. Except for the dichotomous
outcomes, linear regression (dose–response)
analysis, a two-sided test, was performed
using SPSS 10.0 (SPSS, Chicago, IL, USA).
The dichotomous outcomes (medical history)
were analyzed by binary logistic regression
using SPSS 10.0. p-Values were calculated
with standard p = 0.05 as criterion for statisti-
cal signiﬁcance. A best-ﬁtted line was applied
to the scatter diagrams. None of the children
smoked. Correction for mothers who smoked
during pregnancy and/or at the time of test-
ing did not inﬂuence the statistical outcomes
presented here.
Results
Clinical ﬁndings. The medical histories of the
subjects revealed a significant decrease in
allergy in relation to prenatal dioxin exposure
[p = 0.023; slope = –0.141; 95% confidence
interval (CI), 0.769–0.981], as well as in rela-
tion to postnatal exposure (p = 0.030; slope =
–0.060; 95% CI, 0.892–0.994; Table 2). It
must be borne in mind that the deﬁnition of
Children’s Health | ten Tusscher et al.
1520 VOLUME 111 | NUMBER 12 | September 2003 • Environmental Health Perspectives
Table 1. Characteristics of the cohort (n = 27).
Characteristics Occurrence
Sex [n male (%)] 12 (44)
Breast-feeding period (days) 87.6 (7–180)a
Mother’s smoking (n)6
Prenatal dioxin exposure
(ng/kg fat) 27.8 (8.74–46.62)a
Postnatal cumulative dioxin
exposure (ng) 43.4 (4.34–123.72)a
aValues shown are mean (range).allergy in this study is broad. All those report-
ing allergies were female. Linear regression of
only the female subjects showed a more signif-
icant negative relation with prenatal (p =
0.008; slope = –0.035; 95% CI, –0.058 to
–0.011) and postnatal (p = 0.006; slope =
–0.017; 95% CI, –0.028 to –0.006) exposure.
The immunoglobulin E status was not deter-
mined. No relation was seen between the
eosinophil granulocytes and perinatal dioxin
exposure.
We found no relation between perinatal
dioxin exposure and diseases such as otitis,
pneumonia, and chicken pox.
Hematology. The platelet counts ranged
from 248 to 449 × 109/L (mean = 334 ×
109/L, SD = 52.6 × 109/L). The normal range
is from 150 to 350 × 109/L for adults, which
is generally also used for children, although
normal values for children have yet to be thor-
oughly determined. None of the subjects
exhibited thrombocytopenia, whereas nine
children had more platelets than the adult
standard. This is commonly seen in children
and is considered to be without clinical rele-
vance. Linear regression of thrombocytes ver-
sus prenatal dioxin exposure revealed an
insigniﬁcant decrease (p = 0.45; slope = –0.79;
95% CI, –2.91 to 1.33) in relation to increas-
ing exposure. Linear regression of platelets ver-
sus cumulative postnatal exposure revealed a
statistically signiﬁcant decrease (p = 0.04; slope
= –0.67; 95% CI, –1.32 to –0.02) in relation
to increasing exposure (Figure 1). This is simi-
lar to what Pluim et al. (1994) found in the
same children at 11 weeks of age. Based on
these results, the concentration of the platelet
synthesis–regulating protein thrombopoietin
in the frozen plasma was evaluated.
One subject was excluded from the throm-
bopoietin analysis because of a suspected cross-
reaction with the mouse immunoglobulin
antibodies of the thrombopoietin test. The
thrombopoietin concentrations, measured in
the remaining 26 serum samples, ranged from
8 to 42 (mean = 17) aU/mL (arbitrary units
per milliliter). The adult normal values for
thrombopoietin are between 5 and 40 aU/mL.
Thrombocytes versus thrombopoietin revealed
a statistically borderline signiﬁcant inverse cor-
relation (p = 0.07, with a slope of –2.37; 95%
CI, –4.95 to 0.21). This suggests that interfer-
ence in the production of thrombocytes is
more likely than an enhanced destruction as
explanation for the thrombocyte decrease.
Linear regression of thrombopoietin versus
prenatal dioxin exposure revealed an insigniﬁ-
cant increase (p = 0.31; slope = 0.15; 95% CI,
–0.15 to 0.45). Linear regression of thrombo-
poietin versus cumulative postnatal dioxin
exposure revealed a significant increase (p =
0.03; slope = 9.98E-02; 95% CI, 0.008–0.191)
in relation to increasing exposure.
To our knowledge, no studies have shown
a relation between dioxin exposure and
RBC counts. In the present study, such para-
meters as RBC counts and MCV showed no
relation with either prenatal or postnatal
dioxin exposure.
Immunology. We found a significant
increase (p = 0.006; slope = 0.083; 95% CI,
0.026–0.140) in CD4+ (T-helper) cells (mean
= 39.2, range = 25.27–49.05) in relation to
increasing postnatal dioxin exposure. The
T-cell/B-cell ratio (mean = 3.89, range =
1.5–6.2) was borderline signiﬁcantly raised (p
= 0.086; slope = 0.042; 95% CI, –0.006 to
0.090) in relation to the prenatal dioxin expo-
sure. We found a significant increase in the
CD45RA+ cell count (mean = 27.3, range =
16.1–41.3) in relation to the postnatal dioxin
exposure (p = 0.019, slope = 0.078, 95% CI,
0.014–0.141). Other immunologic parameters
revealed no relation with either the prenatal or
postnatal dioxin exposure.
Discussion
Although the somewhat limited size of the
cohort obviously cautions interpretation of the
data, we have found indications of persistent
effects of perinatal dioxin exposure in later
childhood. Below we separately discuss our
ﬁndings of a decrease in allergy, relative throm-
bocytopenia, and immunologic disturbances.
Allergy
The observed decrease in allergy was not
altogether unexpected. In another group of
Dutch children, born in the same period as
our subjects, a decrease in allergy in relation
to current levels of PCBs was also detected
(Weisglas-Kuperus et al. 2000).
A decrease in allergy sounds beneﬁcial, but
this may be deceptive. The decrease could
have its pathogenesis in, for example, a rela-
tively deficient immune memory system, an
altered antigen receptor, or an insufficient
mobilization of immune cells. Yet it is also
possible that perinatal dioxin exposure “pro-
tects” against allergies by means of interference
in the Th1:Th2 ratio. However, considering
the toxicity of dioxins, any relation should be
viewed with suspicion.
We are inclined to explain the decrease in
allergy as a long-term effect of perinatal dioxin
exposure because of the relation seen with the
perinatal exposure. However, the current levels
of dioxins and/or PCBs playing a role cannot
be ruled out, because these levels might be
related to the pre- and postnatal exposures.
Among 4-year-olds, the levels of PCBs were
four times higher in breast-fed infants than in
bottle-fed infants (Patandin et al. 1997). The
current levels of dioxins and PCBs in our study
children were not measured. However, with
use of a model, breast-feeding has an effect of
5% higher levels of PCBs and dioxins, at
8 years of age (Patandin et al. 1999).
Laboratory Findings
Platelets in the present study. This study has
shown a signiﬁcant decrease in thrombocytes
and borderline increase in thrombopoietin
concentration, both in relation to perinatal
dioxin exposure. The platelet count and
thrombopoietin concentration show an inverse
relation. This indicates the cause of the relative
thrombocyte decrease to be a suppressed pro-
duction of platelets, rather than increased
destruction (Nathan and Orkin 1998). The
strong inverse correlation between throm-
bopoietin and platelets, as well as the fact that
the scatter diagrams (not shown) reveal clear
gradients, lends credence to the dioxin inﬂu-
ence at the megakaryocyte-to-thrombocyte
differentiation stage or earlier in the throm-
bopoiesis. The signiﬁcant decrease in the num-
ber of granulocytes, as detected by Pluim et al.
(1994) and Weisglas-Kuperus et al. (1995) in
the perinatal period, may support our hypothe-
sis of a production problem at stem cell level,
showing disruption of two cell lines. In this
study, dioxin effects on red blood cells (third
cell line) could not be demonstrated.
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Table 2. Medical history results.
No. (%) Prenatal exposure Postnatal exposure
(n = 27) Slope 95% CI p-Value Slope 95% CI p-Value
Allergy (yes) 8 (30) –0.141 0.769–0.981 0.023* –0.06 0.892–0.994 0.03*
Eczema (yes) 8 (30) –0.11 0.785–1.023 0.105 –0.035 0.919–1.015 0.17
Asthma (yes) 6 (22) –0.038 0.876–1.059 0.436 0.008 0.979–1.038 0.581
Otitis (yes) 9 (33) 0.011 0.923–1.108 0.811 –0.003 0.967–1.029 0.866
*Statistically signiﬁcant.
Figure 1. Scatter diagram of thrombocytes versus
postnatal dioxin exposure, including the thrombo-
cyte counts at 11 weeks after birth, as determined
by Pluim et al. (1994).
800
700
600
500
400
300
200
02 04 0 6 08 0 100 120 140
Cumulative postnatal dioxin exposure (ng)
T
h
r
o
m
b
o
c
y
t
e
s
 
(
×
 
1
0
 
E
9
/
L
)
▼
▲
▼
▲
▼
▼
▼ ▼
▼
▼
▼
▼
▲
▲
▲
▲
▲ ▲ ▲ ▲ ▲
▲
▲
▲
▲
▲
▲
▲
▲
▲
▼
▼
▼
▼▼
▼
▼ ▼
▼ ▼ ▼
▼
▼
▼ ▼
▼
▼
Current counts
Counts at 11 weeks
▼
▲The subjects in this study group all have
thrombocyte and thrombopoietin concentra-
tions falling within the limits of “normal,” as
is to be expected in an “average, healthy” sub-
ject group. However, follow-up far into adult-
hood is certainly justified, to be vigilant for
later clinical problems. We are tempted to
hypothesize that the persistently reduced
number of thrombocytes seen during child-
hood may lead to a clinically evident shortage
in later life, with increased risk of coagulation
problems. This cohort was selected on preg-
nancy and birth-weight optimality. Therefore,
the elicited results may underestimate those in
a general population cohort.
The persistently decreased thrombocyte
count relative to the postnatal dioxin exposure
is remarkable because Pluim et al. (1994), who
studied the same group of children at 11
weeks of age, detected the same. Then, too,
the reduced thrombocyte count was related to
the postnatal dioxin exposure. This might be
caused by a persisting effect of the exposure to
dioxins in the perinatal period. This reduction
can be induced by either a reduced production
of thrombocytes (suggesting dioxin toxicity at
the megakaryocyte level in the bone marrow)
or an increased sequestration of ineffective
platelets (suggesting toxicity at the gene level).
An increased destruction is excluded by the
finding of the inverse correlation between
thrombopoietin and thrombocyte levels. We
hypothesize that dioxins may negatively
inﬂuence the production of platelets, thereby
necessitating a compensatory increase in
thrombopoietin production. It is not known
whether the level of thrombocytes is geneti-
cally determined or if the set point for this
feedback system remains constant throughout
life under healthy circumstances. Should this
be the case, our ﬁndings can be explained as a
toxic effect on this system in the perinatal
period, with effects persisting into later life.
Another explanation for these outcomes is that
we have detected a continuing effect of dioxin
exposure, with current body levels still able to
negatively inﬂuence thrombocytogenesis. This
was seen in Japanese workers after chronic
exposure (Watanabe et al. 2001) and in two
women after acute poisoning (Geusau et al.
2001). The two subjects of the latter study
had current dioxin concentrations 1,000-fold
higher than our cohort subjects, yet the sub-
jects of the Watanabe et al. (2001) study had
levels not much higher than those of the
mothers of our cohort.
Platelets in the animal studies. Zinkl et al.
(1973) described enduring thrombocytopenia
in adult rats and guinea pigs treated with
high-dosage 2,3,7,8-tetrachloro-p-dioxin
(TCDD). Kociba et al. (1976) reported lower
thrombocyte counts for adult rats given 1 µg
TCDD/kg/day, although no difference was
seen between lower dosage and control groups.
In a study of TCDD-treated rhesus monkeys,
McConnell et al. (1978) described hypoplas-
tic bone marrow after single high doses.
Murante and Gasiewicz (2000) reported
effects of TCDD exposure on marrow prog-
enitor cells in mice. Their data indicate that
proliferation and/or differentiation processes
of hemopoietic stem cells are influenced by
TCDD administered 5–6 weeks postpartum.
Bone marrow and megakaryocyte ﬁndings
have been inconsistent (Gupta et al. 1973;
Weissberg and Zinkl 1973; Zinkl et al. 1973).
Fine et al. (1989) reported a reduction in lym-
phocyte stem cells in the offspring after a sin-
gle dose of 10 µg/kg body-weight TCDD in
maternal mice on gestational day 14.
Various dioxin studies have reported bleed-
ing among laboratory animals exposed to diox-
ins, albeit at far higher doses compared with
the perinatal exposure of this study group.
Viluksela et al. (1997, 1998) noted bleeding to
be the most common sign of lethality, apart
from wasting syndrome. They noted signifi-
cantly decreased platelet counts among the
highest exposed groups in their subchronic/
chronic dosage study, with platelet counts par-
ticularly low in rats moribund as a result of
hemorrhage or anemia. They concluded that
hemorrhage, as a cause of death, is a result of
thrombocytopenia and prolonged prothrom-
bin times. Shiverick and Muther (1983)
showed that fetuses of pregnant rats treated
with a daily oral dosage of 1 µg/kg TCDD had
a 66% incidence of visceral lesions, character-
ized by intestinal hemorrhage. Olson et al.
(1990) found gastrointestinal bleeding to be
the most sensitive indicator of in utero expo-
sure to TCDD, in the fetuses of maternal rats
exposed to 1.5 µg/kg. The incidence of bleed-
ing was 7.7 ± 5.5%. Similarly, Gupta et al.
(1973) reported bleeding among TCDD-
treated rats and guinea pigs.
Platelets in the human studies. In a letter to
the editor of The Lancet, Laporte (1977)
focused attention on a study of Vietnamese
exposed to the dioxin-contaminated defoliant
Agent Orange, used extensively during the
Vietnam War. The study reported gastrointesti-
nal bleeding, caused by thrombocytopenia and
prothrombin deﬁciency, related to the dioxin
exposure. Prothrombin deﬁciency might be a
result of vitamin K deﬁciency caused by PCBs
or dioxins, as is hypothesized by Koppe et al.
(1989) and has been found in the rat studies of
Bouwman et al. (1990). Clotting times and
prothrombin times were not measured because
of limited amounts of blood permitted to be
drawn by the institutional ethics committees.
T cells. It has long been known from ani-
mal and human studies that the thymus and
T-helper cell (CD4+) are sensitive to dioxin
exposure (Vos and Moore 1974; Vos et al.
1998; Weisglas-Kuperus et al. 2000; Zinkl et
al. 1973). Most studies have revealed a decrease
in the CD4+ population. In contrast, we have
shown a significant tendency toward an
increasing T-helper cell population with
increasing postnatal dioxin exposure.
Studies in TCDD-sensitive mice revealed
that TCDD might affect polymorphonuclear
cells at the level of hematopoiesis, via a direct
interaction with granulocyte precursor cells,
or modulate polymorphonuclear cells at dif-
ferent stages of maturation. This suggests an
effect on hematopoietic stem cells (Ackerman
et al. 1989).
Total and dioxin TEQ levels in the breast
milk correlated significantly with increased
T-cell subpopulations in human infants of the
Rotterdam study (Weisglas-Kuperus et al.
2000); additionally, significantly decreased
B-cell markers were observed after postnatal
exposure. In a later follow-up study at 42
months of age (Weisglas-Kuperus et al. 2000),
prenatal PCB exposure was associated with an
increased number of peripheral T cells, as well
as with an increased number of CD8+ (cyto-
toxic) and TcRαss+ T cells. At 42 months of
age, prenatal PCB-exposure was also signifi-
cantly related with more CD3+HLA–DR+
(activated) T cells as well as lower antibody
levels to measles and a higher prevalence of
chicken pox. Current PCB levels were associ-
ated with a higher prevalence of recurrent
middle ear infections and a lower prevalence
of allergic reactions, as already mentioned
(Weisglas-Kuperus et al. 1995). The fact that
the results seen are related to different exposures
may indicate that current levels are still high
enough to cause interference in immunology.
Interestingly, our study has shown an increase
in CD45RA+ cells in relation to cumulative
postnatal dioxin exposure. Oughton et al.
(1995) also saw this in their study on long-
term TCDD exposure in mice. We detected
an increase in CD4+ helper T cells in relation
to perinatal dioxin exposure. In the Rotterdam
study the number of CD45RA+ cells correlated
positively with the incidence of bronchitis at
18 months of age, but at 42 months this was
no longer visible (Weisglas-Kuperus et al.
1995, 2000). Otitis and pneumonia were not
related to dioxin exposure, in our study, but
the limited size of our group may play a role
here. However, our cohort showed a reduction
in lung function and increase in bronchial
obstruction, both relative to increasing perinatal
dioxin exposure (ten Tusscher et al. 2001).
In conclusion, perinatal dioxin exposure,
even at Dutch background exposure levels in
1990, produces a persisting negative effect on
thrombocyte numbers, in conjunction with an
increased thrombopoietin concentration, indi-
cating a production problem at stem cell level.
A decrease in allergy and increases in T-helper
cells and CD45RA+ cells were seen in relation
to cumulative postnatal dioxin exposure. This
persistent influence in average children with
Children’s Health | ten Tusscher et al.
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